Relationship of sustained brain natriuretic peptide release after reperfused acute myocardial infarction with gated SPECT infarct measurements and its connection with collagen turnover and left ventricular remodeling

Journal of Nuclear Cardiology

Volumn 15, Issue 5, 2008, Pages 644-654

  Cerisano, Giampaolo ^a   Valenti, Renato ^a   Sciagrà, Roberto ^b   Pucci, Paolo Domenico ^a   Tommasi, Mariasilvia ^b   Raspanti, Silvia ^b   Pupi, Alberto ^b   Dovellini, Emilio Vincenzo ^a   Antoniucci, David ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

collagen; Myocardial infarction; natriuretic peptides; remodeling

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SPIRONOLACTONE; THIENOPYRIDINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY STENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FEMALE; GATED IMAGING; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; IMAGE ANALYSIS; M MODE ECHOCARDIOGRAPHY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SECRETION; RADIOIMMUNOASSAY; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; COLLAGEN; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDES; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR REMODELING;

EID: 50149107226     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2008.06.009     Document Type: Article

References (41)

1. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
2. Morita E., Yasue H., Yoshimuta M., Ogawa H., Jougasaki M., Matsumura T., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
3. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
4. Omland T., Aakvaag A., Bonarjee V.V.S., Caidahl K., Lie R.T., Nilsen D.W.T., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
5. Tsuruda T., Boerrigter G., Huntley B.K., Noser J.A., Cataliotti A., Costello-Boerrigter L.C., et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91 (2002) 1127-1134
6. Chusho H., Nakamura K., Nakao K., Suda M., Kasahara M., Hashimoto R., et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97 (2000) 4239-4244
7. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix. When is enough enough?. Circulation 108 (2003) 1395-1403
8. Tziakas D.N., Chalikias G.K., Hatzinikoloau E.I., Stakos D.A., Tentes I.K., Kortasir A., et al. N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction. Am J Cardiol 96 (2005) 31-34
9. Squire I.B., Evans J., Leong L., Loftus I.M., and Thompson M.M. Plasma MMP-9 amd MMP-2 after acute myocardial infarction in man: Correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 10 (2004) 328-333
10. Magga J., Puhakka M., Hietakorpi S., Punnonen K., Uusimaa P., Risteli J., et al. Atrial natriuretic peptide, B-type natriuretic peptide and serum collagen markers after acute myocardial infarction. J Appl Physiol 96 (2004) 1306-1311
11. Cerisano G., Pucci P.D., Sulla A., Tommasi M.S., Raspanti S., Santoro G.M., et al. Relationship between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol 99 (2007) 651-656
12. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 (2004) 1533-1542
13. Vatner S.F., Baig H., Manders W.T., and Maroko P.R. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 61 (1978) 1048-1056
14. Weiss J.L., Bulkley B.H., Hutchins G.M., and Mason S.J. Two-dimensional echocardiographic recognition of myocardial injury in man: Comparison with postmortem studies. Circulation 63 (1981) 401-408
15. Pandian N.G., Skorton D.J., Collins S.M., Koyanagi S., Kieso R., Marcus M.L., et al. Myocardial infarct size threshold for two-dimensional echocardiographic detection: Sensitivity of systolic wall thickening and endocardial motion abnormalities in small versus large infarcts. Am J Cardiol 55 (1985) 551-555
16. 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92 (1995) 334-341
17. 99mTc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation 101 (2000) 101-108
18. Christian T.F., Schwartz R.S., and Gibbons R.J. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 86 (1992) 81-90
19. Sciagrà R., Imperiale A., Antoniucci D., Migliorini A., Parodi G., Comis G., et al. Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 31 (2004) 969-974
20. Volpi A., De Vita C., Franzosi M.G., Geraci E., Maggioni A.P., Mauri F., et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 88 (1993) 416-429
21. Uusimaa P., Risteli J., Niemela M., Lumme J., Ikaheimo M., Jounela A., et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96 (1997) 2565-2572
22. Cerisano G., Bolognese L., Carrabba N., Buonamici P., Santoro G.M., Antoniucci D., et al. Doppler-derived mitral deceleration time. An early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. Circulation 99 (1999) 230-236
23. Bolognese L., Cerisano G., Buonamici P., Santini A., Santoro G.M., Antoniucci D., et al. Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction. Circulation 96 (1997) 3353-3359
24. O'Connor M.K., Hammel T., and Gibbons R.J. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med 17 (1990) 69-76
25. Germano G., Kiat H., Kavanagh P.B., Moriel M., Mazzanti M., Su H.T., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36 (1995) 2138-2147
26. Poulsen S.H., Høst N.B., Jensen S.E., and Egstrup K. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 101 (2000) 1527-1532
27. Peuhkurinen K.J., Risteli L., Melkko J., Linnaluoto M., Jounela A., and Risteli J. Thrombolysis therapy with streptokinase stimulates collagen break down. Circulation 83 (1991) 1969-1975
28. Risteli J., Elomaa I.N.S., Novamo A., and Risteli L. Radioimmunossay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone degradation. Clin Chem 39 (1993) 635-640
29. Sciagrà R., Parodi G., Pupi A., Migliorini A., Valenti R., Moschi G., et al. Gated SPECT evaluation of outcome after abciximab-supported primary infarct artery stenting for acute myocardial infarction: The scintigraphic data of the abciximab and carbostent evaluation (ACE) randomized trial. J Nucl Med 46 (2005) 722-727
30. St John Sutton M., Pfeffer M.A., Moye L., Plappert T., Rouleau J.L., Lamas G., et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction baseline predictors and impact of long-term use of captopril: Information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 96 (1997) 3294-3299
31. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
32. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2. Lancet 2 (1988) 349-360
33. Jeremy R.W., Hackworthy R.A., Bautovitch G., Hutton B.F., and Harris P.J. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 9 (1987) 989-995
34. Rouleau J.L., de Champlain J., Klein M., Bichet D., Moye L., Packer M., et al. Activation of neurohumoral systems in post infarction left ventricular dysfunction. J Am Coll Cardiol 22 (1993) 390-398
35. de Lemos J.A., and Morrow D.A. Brain natriuretic peptide measurement in acute coronary syndromes: Ready for clinical application?. Circulation 106 (2002) 2868-2870
36. Giannuzzi P., Imparato A., Temporelli P.L., de Vito F., Silva P.L., Scapellato F., et al. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 23 (1994) 1630-1637
37. Jugdutt B.I. Prevention of ventricular remodeling post myocardial infarction: Timing and duration of therapy. Can J Cardiol 9 (1993) 103-114
38. Rohde L.E., Ducharme A., Arroyo L.H., Aikawa M., Sukhova G.H., Lopez-Anaya A., et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99 (1999) 3063-3070
39. Jugdutt B.I. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Disord 3 (2003) 1-30
40. Weber K.T. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation. Circulation 96 (1997) 4065-4082
41. Ibrahim T., Bülow H.P., Hackl T., Hörnke M., Nekolla S.G., Breuer M., et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 49 (2007) 208-216